Ameritas Investment Partners, Inc. Akero Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,175 shares of AKRO stock, worth $138,196. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,175
Previous 5,145
20.02%
Holding current value
$138,196
Previous $120,000
29.17%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AKRO
# of Institutions
193Shares Held
74.2MCall Options Held
429KPut Options Held
591K-
Janus Henderson Group PLC London, X06.12MShares$137 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$122 Million2.2% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$117 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA5.21MShares$117 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$109 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.04B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...